|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/706 | |
| A61K 31/4045 | |||
| A61P 35/02 |
| (11) | Number of the document | 2099451 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07862420.2 |
| Date of filing the European patent application | 2007-11-30 | |
| (97) | Date of publication of the European application | 2009-09-16 |
| (45) | Date of publication and mention of the grant of the patent | 2016-02-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2007/024712 |
| Date | 2007-11-30 |
| (87) | Number | WO 2008/070011 |
| Date | 2008-06-12 |
| (30) | Number | Date | Country code |
| 868388 P | 2006-12-04 | US |
| (72) |
ATADJA, Peter Wisdom, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | COMBINATION OF AN HDAC INHIBITOR AND AN ANTIMETABOLITE |
| COMBINATION OF AN HDAC INHIBITOR AND AN ANTIMETABOLITE |